LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 19.69 | 84.90 | 33 | 1239 | 0.0266 | -0.2168 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 19.69 | 84.90 | 1263 | 1239 | 1.0190 | 1.0098 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 19.69 | 84.90 | 38 | 1239 | 0.0307 | -0.1877 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 19.69 | 84.90 | 1265 | 1239 | 1.0206 | 1.0106 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 21.40 | 84.90 | 52 | 1454 | 0.0357 | -0.1127 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 21.40 | 84.90 | 1353 | 1454 | 0.9301 | 0.9650 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 21.40 | 84.90 | 42 | 1454 | 0.0289 | -0.1578 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 21.40 | 84.90 | 1414 | 1454 | 0.9720 | 0.9862 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 23.10 | 84.90 | 63 | 1616 | 0.0390 | -0.0678 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 23.10 | 84.90 | 1437 | 1616 | 0.8891 | 0.9455 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 23.10 | 84.90 | 70 | 1616 | 0.0433 | -0.0444 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 23.10 | 84.90 | 1585 | 1616 | 0.9807 | 0.9909 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 24.81 | 84.90 | 77 | 1769 | 0.0435 | -0.0220 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 24.81 | 84.90 | 1564 | 1769 | 0.8839 | 0.9444 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 24.81 | 84.90 | 72 | 1769 | 0.0407 | -0.0369 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 24.81 | 84.90 | 1692 | 1769 | 0.9562 | 0.9797 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 26.51 | 84.90 | 103 | 1923 | 0.0536 | 0.0439 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 26.51 | 84.90 | 1596 | 1923 | 0.8299 | 0.9189 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 26.51 | 84.90 | 86 | 1923 | 0.0447 | 0.0029 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 26.51 | 84.90 | 1733 | 1923 | 0.9011 | 0.9543 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 28.21 | 84.90 | 106 | 2091 | 0.0507 | 0.0492 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 28.21 | 84.90 | 1713 | 2091 | 0.8190 | 0.9155 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 28.21 | 84.90 | 99 | 2091 | 0.0473 | 0.0338 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 28.21 | 84.90 | 1904 | 2091 | 0.9103 | 0.9598 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 29.92 | 84.90 | 121 | 2237 | 0.0541 | 0.0780 | MN20160318_Q02 | E16 |